Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension - Wikidata - wikimedia - TriplyDB

Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension

Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension

http://www.wikidata.org/entity/Q28575913

about

Antibodies in the pathogenesis of hypertension Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats.Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.Antibodies to the α1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiography The immunological basis of hypertension Autoimmunity: an underlying factor in the pathogenesis of hypertension.Preventing autoimmunity protects against the development of hypertension and renal injury.Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit Receptor-activating autoantibodies and disease: preeclampsia and beyond.Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia.Implications of a vasodilatory human monoclonal autoantibody in postural hypotension B cells as under-appreciated mediators of non-auto-immune inflammatory disease.Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function Activating autoantibodies and cardiovascular disease.The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors.Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review.Device-Based Approaches for the Treatment of Arterial Hypertension.Understanding mechanisms of hypertension in systemic lupus erythematosus.Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease Associations of Variants in the CACNA1A and CACNA1C Genes With Longitudinal Blood Pressure Changes and Hypertension Incidence: The GenSalt Study Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia.Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia.National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence.Doxazosin attenuates renal matrix remodeling mediated by anti-α1-adrenergic receptor antibody in a rat model of diabetes mellitus.Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway.Association analysis about HLA-DRB1, -DQB1 polymorphism and auto-antibodies against α(1)-adrenergic receptors in Chinese patients with essential hypertension.Autoantibodies against AT1 and α1-adrenergic receptors predict arterial stiffness progression in normotensive subjects over a 5-year period.Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies.Autoantibodies against angiotensin and adrenergic receptors: more than a biomarker?Functional autoantibodies in patients with different forms of dementia.

P2860

1e73a4512f9786b9fe69f789bbdab82a723b028a

P248

Q26828588-057ADCAD-7305-4124-84E5-A9E37CDCB687 Q27027039-91D36D31-D7EF-41E7-B406-9A1F2389A6A9 Q33535920-DF673164-EFA4-42E8-A8E5-48281439B9FD Q34244290-429EABD2-F8C7-424D-91E8-82C83B816047 Q34331407-CED51977-3E86-4ECC-92F1-B6C5F69B422C Q34364148-ECFB1614-F95D-441B-91CB-889349622062 Q34683745-16FC1096-5B3E-4586-9176-8F1B9B5673C8 Q35116086-B6552359-BAE3-4C4C-BB4B-03B5580F2298 Q35159241-D0A6CDDC-BD56-4C39-BD75-FA20E1968E57 Q35175458-A672A610-79ED-4C01-8B18-2C47FAD50EF0 Q35707881-6FF89E79-435D-4AD3-8271-136E3F7B0808 Q36683260-AC1E54B8-5A2B-493D-816A-86CB025EABD1 Q36836373-55EBBA5C-CC7D-4B92-B479-289941816E3B Q37234140-2CC88EC4-2711-457E-BA32-ACAC5F106069 Q37728724-7A765859-1947-419C-92EA-33EA7DAF0367 Q37973384-0CE30B0A-4E02-46F5-941C-29ABD731E919 Q38118625-1DC18ADF-9709-4052-9318-2C880BE0ADE6 Q38171958-89DE6D2E-B180-454D-8FD3-CBDF3106C16C Q38207936-5722C416-2E12-43B3-B666-99DFB7E63960 Q38336214-76B5F444-D738-48FC-A64D-17EE2E98B402 Q38652607-17A37BB0-5638-435D-9FCE-0CB120593379 Q38722982-3C6F3781-DD8A-44B7-B933-91D0B61EE31F Q38777852-92CFFDDD-C38D-4CB8-A6DB-0D824F2D954B Q38938727-4CE347D5-6634-4E2B-9155-6008A9C57C43 Q39083135-6E30FAAB-7E46-4409-BFCA-E1B8B31288A6 Q39198610-7BC219A9-ABF9-4922-8742-46C0F22C9175 Q39378416-1E2B3F87-C540-462E-89F4-62FCE6AA8DCE Q39409827-ABC1BBE8-4956-4691-96E6-AAB643C5D282 Q39837503-2F1116CB-AA7F-4928-8F41-9D1D1C5305A6 Q40690970-2EC4470E-DFEF-4A9F-8661-06E961D6FB46 Q41672015-499AD7E5-C909-4DB1-A13E-93D49A4523A4 Q42652420-5D4FDFF7-F646-4AD8-BB7F-BB3C28AF1705 Q42796924-0300018B-2287-44B2-B82E-D4DDFBA8A504 Q47447474-8F426D01-E631-4D79-AC18-05C00FA1585B Q48638550-0E0E4C17-D411-40A6-8898-4651CF79ADF1 Q50077615-66676456-B19D-43C2-92D1-8335A408F33D Q52807608-76ABB1E9-371A-4601-AED0-9201BDEEDC13

P2860

Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension

http://www.wikidata.org/entity/Q28575913

description

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique PLoS ONE

@fr

artículu científicu espublizáu en 2008

@ast

scientific journal article

@en

vedecký článok (publikovaný 2008/01/01)

@sk

vědecký článek publikovaný v roce 2008

@cs

wetenschappelijk artikel (gepubliceerd op 2008/01/01)

@nl

wissenschaftlicher Artikel

@de

наукова стаття, опублікована в січні 2008

@uk

name

Potential relevance of alpha(1 ...... ies in refractory hypertension

@ast

Potential relevance of alpha(1 ...... ies in refractory hypertension

@en

Potential relevance of alpha(1 ...... ies in refractory hypertension

@nl

type

label

Potential relevance of alpha(1 ...... ies in refractory hypertension

@ast

Potential relevance of alpha(1 ...... ies in refractory hypertension

@en

Potential relevance of alpha(1 ...... ies in refractory hypertension

@nl

prefLabel

Potential relevance of alpha(1 ...... ies in refractory hypertension

@ast

Potential relevance of alpha(1 ...... ies in refractory hypertension

@en

Potential relevance of alpha(1 ...... ies in refractory hypertension

@nl

P1433

Q28575913-EB1E6295-0F38-4546-B646-2C7CCE56C2E3

P1476

Q28575913-1CE9CCC4-A6B3-403E-9517-DF0D1B9D9F03

P2093

Q28575913-00DD2B58-D7B3-40F8-97DC-3D31DA979C5E

Q28575913-0FD5DDAA-83A9-42DD-98EB-388541939299

Q28575913-25D4F114-8504-4920-AF76-CFCBE2A0DF82

Q28575913-2B9FCCA1-6A88-4423-B4AF-6D35101FA36A

Q28575913-4388BB74-61F6-4A31-96DA-AB7C3C8183D6

Q28575913-4F0AEAB2-BE09-42CC-8F2E-90E4DAF3E9F7

Q28575913-5CDDA42C-83D3-4246-9B9C-DF45BBE4863E

Q28575913-5FBEAA3D-F1BD-4685-BCB1-4D22AAE4C91B

Q28575913-B66F759D-7263-4AB8-8EF6-32A1155618FC

Q28575913-C0C5BD55-63DA-4383-BCE5-844B8A95A28A

P2860

Q28575913-006BB353-54AE-46E7-89A8-BD0E9B4AD38E

Q28575913-017723AD-56EA-4A2F-9AB2-D96AD9D4BC9C

Q28575913-04548979-73FD-4239-8344-CBE646256E2F

Q28575913-0E115813-2343-4AD7-B440-1BF8058252ED

Q28575913-1968D79D-F97F-4A46-BCC4-244C3631DE8A

Q28575913-1CF87C57-D1B8-437D-A94D-1F4C8B29022A

Q28575913-250FF4AB-7C0A-40DB-8DC0-B5CDF03C3D46

Q28575913-25143F0C-DAB8-41E9-88AA-40C900D59F87

Q28575913-329F7299-5B2C-45E2-9AA0-0F2958F0C680

Q28575913-4108F058-B621-431B-900A-D305E26B60B5

P304

Q28575913-CE15A992-AD15-4C78-8189-68E467136943

P31

Q28575913-D53646D1-514B-4B7C-AD50-16B4E46B8DB5

P356

Q28575913-135BE68D-DEA0-4308-8CBF-5F922D45C717

P407

Q28575913-51F45775-B3CB-4731-A72E-EC3954EAD7D9

P433

Q28575913-E445E61F-07DE-415A-9CBF-01D3A826BFF8

P478

Q28575913-865A7D52-DB00-4FE0-886B-B2E2872258FE

P50

Q28575913-09F3748D-3DC8-4D89-A1FA-ED0C1FC018E8

Q28575913-3B5DDA43-B188-4A86-81CB-16485B15AB95

Q28575913-BBD44F73-7A3C-4C8A-83D4-2EE989635BF8

Q28575913-C9ABA216-5767-43D2-808D-634F7F74C65C

Q28575913-CEF99C2D-6117-43B6-8B5B-E48727DF0BE7

Q28575913-DCE2E872-4D07-4C95-8980-20FC6473FC58

P577

Q28575913-F07FED05-72A1-460A-877A-25CBC26CF7B2

P5875

Q28575913-EE0F6BB9-832D-421E-8FA1-9BB630EB1A0C

P698

Q28575913-BFAEB534-B5B5-4F99-A19D-3F964B365F5F

P921

Q28575913-022552FB-E51B-4BF5-92EA-CD088106E377

Q28575913-168FC4B3-95F2-4C83-8ABB-0650ABA17507

P932

Q28575913-6C9ACA77-FE6D-4198-BE2E-5BC4EC2024C6

P356

JOURNAL.PONE.0003742

P1433

P1476

Potential relevance of alpha(1 ...... ies in refractory hypertension

@en

P2093

Carsten Lindschau

http://www.w3.org/2001/XMLSchema#string

Christoph Schroeder

http://www.w3.org/2001/XMLSchema#string

Hannelore Haase

http://www.w3.org/2001/XMLSchema#string

Herbert Schulz

http://www.w3.org/2001/XMLSchema#string

Ingo Morano

http://www.w3.org/2001/XMLSchema#string

Katrin Wenzel

http://www.w3.org/2001/XMLSchema#string

Marion Janczikowski

http://www.w3.org/2001/XMLSchema#string

Norbert Hubner

http://www.w3.org/2001/XMLSchema#string

Peter Karczewski

http://www.w3.org/2001/XMLSchema#string

Rainer Dietz

http://www.w3.org/2001/XMLSchema#string

P2860

alpha(1)-adrenoceptor subtypes differentially couple to growth promotion and inhibition in Chinese hamster ovary cells

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Summaries of Affymetrix GeneChip probe level data

Alpha1-adrenergic receptors: new insights and directions

The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse

c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

alpha1-adrenoceptor stimulation potentiates L-type Ca2+ current through Ca2+/calmodulin-dependent PK II (CaMKII) activation in rat ventricular myocytes.

Roles of secretory phospholipases A(2) in inflammatory diseases and trauma.

The L-type calcium channel in the heart: the beat goes on

P304

e3742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0003742

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Friedrich C. Luft

Stefan Verlohren

Dominik N. Muller

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23475999

http://www.w3.org/2001/XMLSchema#string

P698

19011682

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

2580028

http://www.w3.org/2001/XMLSchema#string